Lazard Asset Management
ANIK icon

Lazard Asset Management’s Anika Therapeutics ANIK Stock Holding History

Lazard Asset Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,730
Closed -$43K – 2254
2024
Q2 		$43K Sell
1,730
-5,373
-76% -$139K ﹤0.01% 1951
2024
Q1 		$180K Buy
+7,103
New +$172K ﹤0.01% 1336
2023
Q4 		– Sell
-7,909
Closed -$147K – 2243
2023
Q3 		$147K Buy
+7,909
New +$164K ﹤0.01% 1489
2023
Q1 		– Sell
-2,651
Closed -$78K – 2283
2022
Q4 		$78K Hold
2,651
– – ﹤0.01% 1616
2022
Q3 		$63K Hold
2,651
– – ﹤0.01% 1687
2022
Q2 		$59K Buy
+2,651
New +$59.1K ﹤0.01% 1734
2022
Q1 		– Sell
-1,277
Closed -$45K – 2319
2021
Q4 		$45K Hold
1,277
– – ﹤0.01% 1780
2021
Q3 		$54K Buy
+1,277
New +$52.6K ﹤0.01% 1644
2021
Q2 		– Sell
-1,791
Closed -$73K – 1951
2021
Q1 		$73K Sell
1,791
-331
-16% -$12.6K ﹤0.01% 1284
2020
Q4 		$96K Sell
2,122
-36
-2% -$1.37K ﹤0.01% 1191
2020
Q3 		$76K Hold
2,158
– – ﹤0.01% 1070
2020
Q2 		$81K Buy
2,158
+302
+16% +$9.95K ﹤0.01% 1069
2020
Q1 		$53K Buy
+1,856
New +$75.1K ﹤0.01% 1152

Other funds holding ANIK

TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lazard Asset Management's ANIK Position: Q3 2024 in Review

Lazard Asset Management sold out of Anika Therapeutics (ANIK) in Q3 2024, closing a stake of 1,730 shares — an estimated $43K sold.

Lazard Asset Management first reported a position in ANIK in Q1 2020 and held it in 13 quarters. The position peaked at $180K in Q1 2024. 122 funds tracked by Wall St. Rank hold ANIK as of Q3 2024.

  • Lazard Asset Management reported no remaining Anika Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Lazard Asset Management sold 1,730 Anika Therapeutics shares in Q3 2024, an estimated $43K.
  • Lazard Asset Management first reported a position in Anika Therapeutics in Q1 2020 and held it in 13 quarters.
  • Lazard Asset Management's Anika Therapeutics position peaked at $180K in Q1 2024.
  • 122 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2024.

Based on Lazard Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.